Aldosterone

Aldosterone

SCHEMBL21082811

C[C@]12CCC(=O)C=C1CC[C@@H]1[C@@H]2[C@@H](O)C[C@]2(C=O)[C@@H](C(=O)CO)CC[C@@H]12.[PbH2]

nearest known ligand 0.98

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C2 P08235 7/20 0.98
SHBG P04278 4/20 0.98
SERPINA6 P08185 4/20 0.98
PRKAA2 P54646 1/20 0.98
SMN1; SMN2 Q16637 6/20 0.76
HIF1A Q16665 6/20 0.76
LMNA P02545 4/20 0.76
HSD17B10 Q99714 4/20 0.76
MAPT P10636 3/20 0.76
CYP3A4 P08684 3/20 0.76
NFKB1 P19838 2/20 0.76
MAPK1 P28482 2/20 0.76
BLM P54132 1/20 0.76
CYP2C9 P11712 1/20 0.76
TSHR P16473 1/20 0.76
SLC22A2 O15244 1/20 0.76
SLC22A1 O15245 1/20 0.76
SLC22A3 O75751 1/20 0.76
THPO P40225 1/20 0.76
MTOR P42345 1/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Aldosterone SCHEMBL21950215 0.99 NR3C2 (1.00) NR3C2SHBGSERPINA6PRKAA2SMN1; SMN2
Aldosterone SCHEMBL1675 0.99 NR3C2 (1.00) NR3C2SHBGSERPINA6PRKAA2SMN1; SMN2
Aldosterone SCHEMBL7191919 0.99 NR3C2 (1.00) NR3C2SHBGSERPINA6PRKAA2SMN1; SMN2
Aldosterone SCHEMBL19327156 0.99 NR3C2 (1.00) NR3C2SHBGSERPINA6PRKAA2SMN1; SMN2
Aldosterone SCHEMBL600774 0.99 NR3C2 (1.00) NR3C2SHBGSERPINA6PRKAA2SMN1; SMN2
Aldosterone SCHEMBL14373307 0.99 NR3C2 (1.00) NR3C2SHBGSERPINA6PRKAA2SMN1; SMN2
Aldosterone SCHEMBL15935548 0.99 NR3C2 (1.00) NR3C2SHBGSERPINA6PRKAA2SMN1; SMN2
Aldosterone SCHEMBL21267959 0.98 NR3C2 (0.98) NR3C2SHBGSERPINA6PRKAA2SMN1; SMN2
Aldosterone SCHEMBL27949081 0.98 NR3C2 (0.98) NR3C2SHBGSERPINA6PRKAA2SMN1; SMN2
Aldosterone SCHEMBL11145028 0.96 NR3C2 (0.94) NR3C2SHBGSERPINA6PRKAA2SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240016796-A1 Pharmaceutical Composition Comprising Mineralocorticoid Receptor Antagonist and Use Thereof NOVO NORDISK A/S (DK) 2024-01-18 US disclosed
US-11806344-B2 Pharmaceutical composition comprising mineralocorticoid receptor antagonist and use thereof KBP BIOSCIENCES PTE. LTD. (SG) 2023-11-07 US disclosed
EP-3517113-A1 PHARMACEUTICAL COMPOSITION COMPRISING MINERALOCORTICOID RECEPTOR ANTAGONIST AND USE THEREOF KBP Biosciences Co., Ltd. (CN) 2019-07-31 EP disclosed
US-20190201390-A1 PHARMACEUTICAL COMPOSITION COMPRISING MINERALOCORTICOID RECEPTOR ANTAGONIST AND USE THEREOF KBP BIOSCIENCES CO., LTD. (CN) 2019-07-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240016796-A1 Pharmaceutical Composition Comprising Mineralocorticoid Receptor Antagonist and Use Thereof NR3C2, MC2R, REN NR3C2 1/4885SHBG 78/4885SERPINA6 89/4885
US-20190201390-A1 PHARMACEUTICAL COMPOSITION COMPRISING MINERALOCORTICOID RECEPTOR ANTAGONIST AND USE THEREOF NR3C2, MC2R, REN NR3C2 1/4885SHBG 78/4885SERPINA6 89/4885
US-11806344-B2 Pharmaceutical composition comprising mineralocorticoid receptor antagonist and use thereof NR3C2, MC2R, REN NR3C2 1/4885SHBG 78/4885SERPINA6 89/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.